Logo

U.S. FDA Approves Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Born During or Entering Their First RSV Season - Merck.com

Last Updated: 20.06.2025 04:25

U.S. FDA Approves Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Born During or Entering Their First RSV Season - Merck.com

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) has ap… [+11553 chars]

RAHWAY, N.J.--(BUSINESS WIRE)--

June 9, 2025 3:11 pm ET

Jenny from Perth writes – my partner is the life of the party, women and men adore him. But at home, he gets angry at us for the silliest reasons and never nice words me or our kids, always putting us down. Should I stay or leave him?